Arkema's full year 2007 sales stood at €5,675 million, slightly up on its 2006 sales of €5,664 million, a 4% increase excluding foreign exchange rate effect and variations in the scope of business.
This increase resulted from a sound organic growth in volumes (+2.3%) sustained in particular by the development of Arkema's activities in Asia and by targeted projects in North America and in Europe (unit extensions in Industrial Chemicals and launch of new products in Performance Products).
This improvement is also due to Arkema's ongoing policy to selectively increase its sales prices (+1.7%) across its three business segments in order to offset the impact of raw material and energy price rises.
The impact on sales of the conversion effect, due primarily to the decline in the US dollar versus euro conversion rate, stood at –2.6%.
Variations in the scope of business resulting in particular from portfolio management (acquisition of Coatex, and divestment of Amines in the United States as well as Urea Formaldehyde Resins) had a negative impact of 1.2% on sales.
In the 4th quarter, the change in the sales consolidation method for some subsidiaries resulted in a €29 million decrease in Performance Products sales.